AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

The active pharmaceutical ingredient manufacturing facilities are part of a broader $100 billion investment commitment to strengthen the company’s U.S. manufacturing capabilities.

AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...

AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...

Spring Modulith supports the development of functionally modularized Spring Boot applications. With Spring Modulith, it is possible to divide Spring Boot applications into functional modules with ...

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

The unified JavaScript runtime standard is an idea whose time has come. Here’s an inside look at the movement for server-side JavaScript interoperability.

ByteDance's viral video generation model Seedance 2.0 was closely integrated with the Spring Festival gala's programming on Monday night China's "big tech" giants - including Alibaba Group Holding, ...

This is the next in the series of investments from AbbVie to expand U.S. pharmaceutical manufacturing.